Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Xavier Montalban: a pioneer in understanding multiple sclerosis.
The therapeutic value of yoga in neurological disorders.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
CD8-mediated inflammatory central nervous system disorders.
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
Cerebrospinal fluid analysis.
Neuroprotection With Phenytoin in Optic Neuritis
Immunosuppressive monoclonal antibodies: current and next generation.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
Structural connectomics in brain diseases.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
Minocycline effects on the CSF proteome of Experimental Autoimmune Encephalomyelitis rats.
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis.
Pages
« first
‹ previous
…
196
197
198
199
200
201
202
203
204
…
next ›
last »